Jailani, Jelpin J.
HRN: 27-03-56 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/25/2025
CEFUROXIME 1.5GM (VIAL)
04/25/2025
05/02/2025
IV
1.5grams
Every 8hrs
Open Fracture, Tibia, Left
Waiting Final Action
Indication: Empiric Type of Infection: Bone & JointSkin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes